26685-57-4

Usage

Uses

Used in Maternal Health Monitoring:
PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEIN is used as a biomarker for monitoring maternal health during pregnancy. It helps in the early detection of pregnancy-related complications such as preeclampsia and gestational diabetes, allowing for timely intervention and management.
Used in Fetal Health Assessment:
PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEIN is used as an indicator of fetal growth and development. Its levels can provide insights into the health and well-being of the developing fetus, assisting in the identification of potential issues that may require medical attention.
Used in Immunological Research:
PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEIN is used as a subject of study in immunological research. Its role in modulating the maternal immune response and promoting immunological tolerance to the developing fetus makes it a valuable tool for understanding the complex interactions between the maternal and fetal immune systems.
Used in Angiogenesis and Tumor Growth Studies:
PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEIN is used as a research subject in the study of angiogenesis and tumor growth. Its involvement in the regulation of these processes provides valuable insights into the mechanisms underlying various pathological conditions and potential therapeutic targets.
Used in Pharmaceutical Development:
PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEIN is used as a target for the development of pharmaceuticals aimed at improving pregnancy outcomes and managing pregnancy-related complications. Understanding its role in various biological processes can lead to the discovery of novel therapeutic agents that can modulate its activity for the benefit of maternal and fetal health.

InChI:InChI=1/C26H37NO2/c1-7-9-10-11-18(3)19(4)20-15-23(28)25-21-17-27(13-8-2)14-12-22(21)26(5,6)29-24(25)16-20/h2,15-16,18-19,28H,7,9-14,17H2,1,3-6H3

Upstream product

• 26685-53-0 5,5-dimethyl-8-(1,2-dimethylheptyl)-10-hydroxy-1,2,3,4-tetrahydro-5H-[1]benzopyrano[4,3-c]pyridine 
• 106-96-7 propargyl bromide 
• 271242-28-5 2-[1-benzyl-4-(1-hydroxy-1-methyl-ethyl)-1,2,5,6-tetrahydro-pyridin-3-yl]-5-(1,2-dimethyl-heptyl)-benzene-1,3-diol 
• 26685-45-0 2-benzyl-8-(1,2-dimethyl-heptyl)-10-hydroxy-1,2,3,4-tetrahydro-chromeno[4,3-c]pyridin-5-one 
• 10436-52-9 5-(1,2-dimethyl-heptyl)-benzene-1,3-diol 
• 52763-21-0 ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride 
• 26685-47-2 2-benzyl-8-(1,2-dimethyl-heptyl)-5,5-dimethyl-1,3,4,5-tetrahydro-2H-chromeno[4,3-c]pyridin-10-ol 
• 26685-45-0 2-benzyl-8-(1,2-dimethyl-heptyl)-10-hydroxy-1,2,3,4-tetrahydro-chromeno[4,3-c]pyridin-5-one 
• 10436-52-9 5-(1,2-dimethyl-heptyl)-benzene-1,3-diol 
• 26685-47-2 2-benzyl-8-(1,2-dimethyl-heptyl)-5,5-dimethyl-1,3,4,5-tetrahydro-2H-chromeno[4,3-c]pyridin-10-ol 
• 26685-45-0 2-benzyl-8-(1,2-dimethyl-heptyl)-10-hydroxy-1,2,3,4-tetrahydro-chromeno[4,3-c]pyridin-5-one 
• 10436-52-9 5-(1,2-dimethyl-heptyl)-benzene-1,3-diol 
• 26685-47-2 2-benzyl-8-(1,2-dimethyl-heptyl)-5,5-dimethyl-1,3,4,5-tetrahydro-2H-chromeno[4,3-c]pyridin-10-ol 
• 26685-45-0 2-benzyl-8-(1,2-dimethyl-heptyl)-10-hydroxy-1,2,3,4-tetrahydro-chromeno[4,3-c]pyridin-5-one 

Relevant academic research and scientific papers

Soft cannabinoid analogues as potential anti-glaucoma agents

Cannabinoids have intraocular pressure (IOP) lowering effects, thus, they have a therapeutic potential in the treatment of glaucoma. Unfortunately, in the same time, they show CNS and cardiovascular effects as well. Our aim was to develop a safer, cannabi

Drugs derived from cannabinoids. 1. Nitrogen analogs, benzopyranopyridines and benzopyranopyrroles

Various nitrogen analogs of Δ(6a,10a) tetrahydrocannabinol were synthesized by a general procedure described in an earlier communication. Minimum effective doses (MED(50's)) and lethal doses (LD(50's)) were determined by a modified Irwin mouse screen afte